Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The ongoing dilemma of prophylactic platelet transfusions pre-procedure and the development of evidence-based recommendations.

Stanworth SJ. et al, (2023), Transfus Med

The ISTH SSC subcommittee on Hemostatic Management of Patients with Liver Disease: goals, ambitions, and call for collaboration: reply.

Lisman T. et al, (2023), J Thromb Haemost, 21, 2632 - 2633

Prophylactic Platelet Transfusion: Is There Evidence of Benefit, Harm, or No Effect?

Maier CL. et al, (2023), Transfus Med Rev

Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review.

Mo A. et al, (2023), Blood Rev

Definitions of massive transfusion in adults with critical bleeding: a systematic review.

Lin VS. et al, (2023), Crit Care, 27

Continuation of therapeutic dose heparin for critically ill patients with COVID-19.

Bradbury CA. et al, (2023), Intensive Care Med, 49, 873 - 875

Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial.

Desborough MJR. et al, (2023), Lancet Neurol, 22, 557 - 567

Cost Effectiveness of Different Platelet Preparation, Storage, Selection and Dosing Methods in Platelet Transfusion: A Systematic Review.

Laermans J. et al, (2023), Pharmacoecon Open

Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes.

Loke J. et al, (2023), Br J Haematol

Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews.

Lewis SR. et al, (2023), Cochrane Database Syst Rev, 6

Granulocyte transfusion during cord blood transplant for relapsed, refractory AML is associated with massive CD8+ T-cell expansion, significant cytokine release syndrome and induction of disease remission.

Borrill R. et al, (2023), Br J Haematol

The ISTH SSC Subcommittee on Hemostatic Management of Patients with Liver Disease: goals, ambitions, and call for collaboration

Lisman T. et al, (2023), Journal of Thrombosis and Haemostasis, 21, 1073 - 1074

Experience With IVDR Implementation in Three Diagnostic Laboratories: Messages to EU Health Institutions, Diagnostic Healthcare Payers, and Authorities.

Lubbers BR. et al, (2023), HemaSphere, 7

Two-year outcomes following a randomised platelet transfusion trial in preterm infants.

Moore CM. et al, (2023), Arch Dis Child Fetal Neonatal Ed

How I diagnose and treat neonatal thrombocytopenia.

Stanworth SJ. and Mumford AD., (2023), Blood

Traumatic coagulopathy in the older patient: analysis of coagulation profiles from the Activation of Coagulation and Inflammation in Trauma-2 (ACIT-2) observational, multicenter study

Curry NS. et al, (2023), Journal of thrombosis and haemostasis : JTH, 21, 215 - 226

Survey of transfusion practices in preterm infants in Europe.

Scrivens A. et al, (2023), Arch Dis Child Fetal Neonatal Ed

Association of red blood cells and plasma transfusion versus red blood cell transfusion only with survival for treatment of major traumatic hemorrhage in prehospital setting in England: a multicenter study.

Tucker H. et al, (2023), Crit Care, 27

Cost-Effectiveness of Thrombopoietin Mimetics in Patients with Thrombocytopenia: A Systematic Review

Van Remoortel H. et al, (2023), PharmacoEconomics

Journal Club

Stanworth SJ. et al, (2023), TRANSFUSION MEDICINE REVIEWS, 37, 45 - 52

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?